Metabolomics analysis to discover biomarkers of glaucoma

Metabolomics analysis to discover biomarkers of glaucoma - Metabolomics analysis to discover biomarkers of glaucoma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000049651

Enrollment

1400

Registered

2022-12-20

Start date

2022-12-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary open-angle glaucoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cases: Those diagnosed with primary open-angle glaucoma after a detailed ophthalmologic examination at Tohoku University Hospital. Control: In the Tohoku Medical Megabank Organization cohort, subjects with no history of glaucoma and no optic nerve cupping on fundus examination.

Exclusion criteria

Exclusion criteria: As stated in the selection criteria.

Design outcomes

Primary

Measure	Time frame
Plasma metabolite concentrations obtained by nuclear magnetic resonance (NMR)	—

Countries

Japan

Contacts

Public ContactKota Sato

Tohoku University Depertment of Ophthalmology

satokota@oph.med.tohoku.ac.jp022-717-7294

Outcome results